X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
0
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-galafold-migalastat-hydrochloride-12390.pdf
https://www.globenewswire.com/news-release/2022/04/19/2424256/15991/en/Amicus-Announces-Issuance-of-New-U-S-Composition-of-Matter-Patent-for-Galafold-migalastat-Strengthening-Patent-Protection-Through-2038.html
https://www.fiercebiotech.com/biotech/amicus-spins-off-gene-therapy-unit-600m-spac-deal-as-ceo-moves-over-to-caritas-therapeutics
https://pharmaphorum.com/news/chiesis-flagship-fabry-drug-heads-for-fda-verdict-in-early-2021/
https://endpts.com/amicus-penn-expand-gene-therapy-research-agreement-into-five-year-collaboration/
https://blogs.sciencemag.org/pipeline/archives/2019/02/04/2018-drug-approvals-a-closer-look?r3f_986=https://www.google.com/
http://www.pmlive.com/pharma_news/orphan_drugs_from_biogen_and_amicus_win_uk_prix_galien_1260764
https://www.biospace.com/article/fda-approves-eight-novel-drugs-in-august-fd1a-/
https://www.cnbc.com/2018/08/10/globe-newswire-fda-approves-galafolda-migalastat-for-the-treatment-of-certain-adult-patients-with-fabry-disease.html
https://endpts.com/once-stiff-armed-at-the-fda-new-management-offers-amicus-a-warm-embrace-and-marketing-ok-for-galafold/
http://ir.amicusrx.com/news-releases/news-release-details/amicus-therapeutics-launches-galafoldr-migalastat-fabry-disease
https://endpts.com/once-rejected-fda-now-rolls-out-a-short-red-carpet-for-amicus-migalastat/
http://ir.amicusrx.com/news-releases/news-release-details/amicus-therapeutics-present-leerink-partners-7th-annual-global
http://ir.amicusrx.com/news-releases/news-release-details/amicus-therapeutics-launches-galafoldtm-migalastat-treatment-2
http://ir.amicusrx.com/news-releases/news-release-details/amicus-therapeutics-present-leerink-partners-roundtable-series
https://endpts.com/amicus-rare-disease-drug-flunks-a-pivotal-phase-iii-test/
https://globenewswire.com/news-release/2017/03/08/933589/0/en/Amicus-Therapeutics-Launches-Galafold-Migalastat-for-Treatment-of-Fabry-Disease-in-Italy.html
http://www.pharmatimes.com/news/amicus_kicks_off_launch_of_galafold_in_the_uk_1187765
http://www.pmlive.com/pharma_news/amicus_gets_nice_green_light_for_fabry_drug_1187341
http://www.pharmatimes.com/news/nice_backs_amicus_galafold_for_fabry_disease_1183225
http://www.biospace.com/News/amicus-plummets-on-3-year-delay-to-u-s-fabry-drug/440288/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews
https://globenewswire.com/news-release/2016/11/28/893242/0/en/Amicus-Therapeutics-Announces-U-S-Regulatory-Pathway-for-Migalastat-for-Fabry-Disease.html
Market Place
Share 
